Source: Newswiretoday
Indian vendors have a huge emerging opportunity in bioinformatics services from pharmaceutical companies in customization of existing products and creation, licensing and manipulation of databases.
Contract research assignments usually generate large amounts of data, leading to problems in data storage, management, retrieval, and analysis. The application of IT to the life sciences sector - bioinformatics, assumes increasingly higher significance as the use of bioinformatics tools lower costs, improve efficiency and reduce development-to-launch timelines.
Indian vendors have a huge emerging opportunity in bioinformatics services, customization of existing products and creation, licensing and manipulation of databases. However, they face certain critical challenges like the lack of standardization in service platforms and modular systems, problem of market / data heterogeneity, and an acute shortage of qualified manpower. They would also need to find a niche focus, in order to move higher up the value chain of services.
However, Indian bioinformatics vendors are aware of these challenges, and have started improving their processes to succeed as preferred outsourcing partners to global research clients. They have enhanced investments in innovation and are also forging partnerships with reputed academic institutes to ensure a healthy flow of employees. Poonam Bhana, analyst at ValueNotes, estimates that “the bioinformatics outsourcing services sector in India will grow at 25% CAGR over the period 2007-2010.”
ValueNotes has launched “CRAMS Insights” - a bimonthly newsletter as an update to the report “Pharma Outsourcing in Drug Discovery & Development: Contract Research Opportunity in India”. The newsletter focuses on shifts in business models, M & A trends, emerging technology platforms, service capabilities of vendors, and a macro level view of the Indian pharmaceutical business against a global backdrop.
